THYNNE + Macartney is giving medical research a leg-up, announcing a partnership worth $25,000 with the Gallipoli Medical Research Foundation (GMRF).
Bill Loughnan, Chairman of Partners at Thynne + Macartney, says the collaboration provides an opportunity for the firm to continue its tradition of giving back to the community.
He also notes that the new partnership strikes an especially personal chord with the firm, considering the history of one of its founders.
"We found GMRF's commitment to the veteran community particularly interesting as one of our founders, Andrew Thynne, was Chairman of the Recruiting Committee during World War I and played an instrumental role in the beginnings of ANZAC Day," he says.
"We wanted to continue the firm's tradition of supporting veterans by helping the Foundation continue to break new ground in the complicated area of Post-Traumatic Stress Disorder."
Loughnan says the partnership with GMRF is a perfect match, as both organisations share a number of core values.
"Our management team spent some time exploring how we wanted to engage with the community, but when we came across Gallipoli Medical Research Foundation, we knew it was the right fit," he says.
"We saw that our values align. Both organisations help people find more freedom, peace of mind and a better sense of control, whether it's around quality of life and health issue or their personal and business life."
GMRF fund and facilitate medical research to prevent, cure or lessen the severity of diseases affecting the veteran and broader Australian community.
Their current work includes a PTSD initiative to study the mental health challenges faced by soldiers attempting to return to civilian life.
Thynne + Macartney will deliver its financial commitment, plus added pro bono work, over the coming four years.
Enjoyed this article?
Don't miss out on the knowledge and insights to be gained from our daily news and features.
Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.
Support independent journalism and stay informed with stories that matter to you.